Evidence map›Paper›PMID 41492396›Full record

ArticleJPRAS open2026

Single stage reconstruction of the right thumbnail with Novosorb® Biodegradable Temporizing Matrix (BTM) following massive glomus tumor resection.

Eimear Phoenix, David Carolan, Robin Caird, Safwat Ibrahim

Abstract readCase Reports
In one paragraph

Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eimear PhoenixRoyal College of Surgeons, St Stephen's Green, Dublin, Ireland.
David CarolanBeaumont Hospital, Beaumont Road, Beaumont, Dublin, Ireland.
Robin CairdBeaumont Hospital, Beaumont Road, Beaumont, Dublin, Ireland.
Safwat IbrahimRoyal College of Surgeons, St Stephen's Green, Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glomus tumors are rare, benign vascular neoplasms arising from glomus bodies, often presenting with localized pain and functional limitation. The tumors commonly arise in the sub-ungual region of the distal phalanx and can be locally destructive, posing a unique reconstructive challenge. Case presentation: We report the case of a 47-year-old male, presenting with a glomus tumor of the distal phalanx of the right thumb, involving more than 70 % of the nailbed resulting in severe pain and functional impairment. Imaging confirmed significant bone erosion of the distal phalanx. Surgical excision with germinal matrix ablation was performed, achieving complete resection. A novel single-stage reconstruction of the right thumb with exposed distal phalanx and nailbed loss was undertaken using a dermal fat graft from the right forearm and Biodegradable Temporizing Matrix (BTM). This approach precluded a complex multi-stage reconstruction and enabled immediate defect coverage and restoration of structural integrity. Outcome: At 4 weeks review, the BTM had fully integrated and was delaminated to reveal a vascularized wound bed. The wound was left to heal by secondary intention and no skin graft was performed. At 6 months post-operatively, functional outcomes were excellent with restoration of full active range of motion without pain or hypersensitivity. Conclusion: This case highlights the efficacy of single-stage BTM reconstruction following glomus tumor excision involving the distal phalanx and nail bed. The approach offers a promising alternative to conventional multi-stage reconstruction, ensuring optimal recovery and function. Further studies are needed to validate the efficacy of BTM in hand reconstruction.

Indexed as

Biodegradable Temporizing MatrixDermal matricesGlomus tumorNailbed reconstructionThumb reconstruction

Identifiers

PMID41492396
PMCPMC12765155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.